Cite
A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)
MLA
Michael Absoud, et al. “A Multicentre RandomiSed Controlled TRial of IntraVEnous Immunoglobulin Compared with Standard Therapy for the Treatment of Transverse Myelitis in Adults and Children (STRIVE).” Health Technology Assessment, vol. 21, no. 31, May 2017. EBSCOhost, https://doi.org/10.3310/hta21310.
APA
Michael Absoud, Peter Brex, Olga Ciccarelli, Onyinye Diribe, Gavin Giovannoni, Jennifer Hellier, Rosemary Howe, Rachel Holland, Joanna Kelly, Paul McCrone, Caroline Murphy, Jackie Palace, Andrew Pickles, Michael Pike, Neil Robertson, Anu Jacob, & Ming Lim. (2017). A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). Health Technology Assessment, 21(31). https://doi.org/10.3310/hta21310
Chicago
Michael Absoud, Peter Brex, Olga Ciccarelli, Onyinye Diribe, Gavin Giovannoni, Jennifer Hellier, Rosemary Howe, et al. 2017. “A Multicentre RandomiSed Controlled TRial of IntraVEnous Immunoglobulin Compared with Standard Therapy for the Treatment of Transverse Myelitis in Adults and Children (STRIVE).” Health Technology Assessment 21 (31). doi:10.3310/hta21310.